The global market for Insomnia Therapy was valued at US$ 3060 million in the year 2024 and is projected to reach a revised size of US$ 4342 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Insomnia Therapy Market

Insomnia is when you aren"t sleeping as you should. That can mean you aren"t sleeping enough, you aren"t sleeping well or you"re having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.

The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.

This report aims to provide a comprehensive presentation of the global market for Insomnia Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapy.

The Insomnia Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insomnia Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insomnia Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Insomnia Therapy Market Report

Report Metric	Details
Report Name	Insomnia Therapy Market
Accounted market size in year	US$ 3060 million
Forecasted market size in 2031	US$ 4342 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Non-pharmacological Therapy Pharmacological Therapy
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & Co., Sanofi, Pfizer, Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare, Pernix Therapeutics, Vanda Pharmaceuticals, ECR Pharmaceuticals, Fidia Farmaceutici, Dainippon Sumitomo, Biocodex, Eli Lilly and Company, Ebb Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Insomnia Therapy Market growing?

Ans: The Insomnia Therapy Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Insomnia Therapy Market size in 2031?

Ans: The Insomnia Therapy Market size in 2031 will be US$ 4342 million.

Who are the main players in the Insomnia Therapy Market report?

Ans: The main players in the Insomnia Therapy Market are Merck & Co., Sanofi, Pfizer, Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare, Pernix Therapeutics, Vanda Pharmaceuticals, ECR Pharmaceuticals, Fidia Farmaceutici, Dainippon Sumitomo, Biocodex, Eli Lilly and Company, Ebb Therapeutics

What are the Application segmentation covered in the Insomnia Therapy Market report?

Ans: The Applications covered in the Insomnia Therapy Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Insomnia Therapy Market report?

Ans: The Types covered in the Insomnia Therapy Market report are Non-pharmacological Therapy, Pharmacological Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Non-pharmacological Therapy

1.2.3 Pharmacological Therapy

1.3 Market by Application

1.3.1 Global Insomnia Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Insomnia Therapy Market Perspective (2020-2031)

2.2 Global Insomnia Therapy Growth Trends by Region

2.2.1 Global Insomnia Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Insomnia Therapy Historic Market Size by Region (2020-2025)

2.2.3 Insomnia Therapy Forecasted Market Size by Region (2026-2031)

2.3 Insomnia Therapy Market Dynamics

2.3.1 Insomnia Therapy Industry Trends

2.3.2 Insomnia Therapy Market Drivers

2.3.3 Insomnia Therapy Market Challenges

2.3.4 Insomnia Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Insomnia Therapy Players by Revenue

3.1.1 Global Top Insomnia Therapy Players by Revenue (2020-2025)

3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Insomnia Therapy Revenue

3.4 Global Insomnia Therapy Market Concentration Ratio

3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2024

3.5 Global Key Players of Insomnia Therapy Head office and Area Served

3.6 Global Key Players of Insomnia Therapy, Product and Application

3.7 Global Key Players of Insomnia Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Therapy Breakdown Data by Type

4.1 Global Insomnia Therapy Historic Market Size by Type (2020-2025)

4.2 Global Insomnia Therapy Forecasted Market Size by Type (2026-2031)

5 Insomnia Therapy Breakdown Data by Application

5.1 Global Insomnia Therapy Historic Market Size by Application (2020-2025)

5.2 Global Insomnia Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Insomnia Therapy Market Size (2020-2031)

6.2 North America Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Insomnia Therapy Market Size by Country (2020-2025)

6.4 North America Insomnia Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Insomnia Therapy Market Size (2020-2031)

7.2 Europe Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Insomnia Therapy Market Size by Country (2020-2025)

7.4 Europe Insomnia Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Insomnia Therapy Market Size (2020-2031)

8.2 Asia-Pacific Insomnia Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Insomnia Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Insomnia Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Insomnia Therapy Market Size (2020-2031)

9.2 Latin America Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Insomnia Therapy Market Size by Country (2020-2025)

9.4 Latin America Insomnia Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Insomnia Therapy Market Size (2020-2031)

10.2 Middle East & Africa Insomnia Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Insomnia Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Insomnia Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck & Co.

11.1.1 Merck & Co. Company Details

11.1.2 Merck & Co. Business Overview

11.1.3 Merck & Co. Insomnia Therapy Introduction

11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2020-2025)

11.1.5 Merck & Co. Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Insomnia Therapy Introduction

11.2.4 Sanofi Revenue in Insomnia Therapy Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Insomnia Therapy Introduction

11.3.4 Pfizer Revenue in Insomnia Therapy Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Takeda Pharmaceutical Company Ltd.

11.4.1 Takeda Pharmaceutical Company Ltd. Company Details

11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview

11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction

11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2020-2025)

11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development

11.5 Purdue Pharmaceuticals L.P.

11.5.1 Purdue Pharmaceuticals L.P. Company Details

11.5.2 Purdue Pharmaceuticals L.P. Business Overview

11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction

11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2020-2025)

11.5.5 Purdue Pharmaceuticals L.P. Recent Development

11.6 Eisai, Co. Ltd.

11.6.1 Eisai, Co. Ltd. Company Details

11.6.2 Eisai, Co. Ltd. Business Overview

11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction

11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2020-2025)

11.6.5 Eisai, Co. Ltd. Recent Development

11.7 Meda Consumer Healthcare

11.7.1 Meda Consumer Healthcare Company Details

11.7.2 Meda Consumer Healthcare Business Overview

11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction

11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2020-2025)

11.7.5 Meda Consumer Healthcare Recent Development

11.8 Pernix Therapeutics

11.8.1 Pernix Therapeutics Company Details

11.8.2 Pernix Therapeutics Business Overview

11.8.3 Pernix Therapeutics Insomnia Therapy Introduction

11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2020-2025)

11.8.5 Pernix Therapeutics Recent Development

11.9 Vanda Pharmaceuticals

11.9.1 Vanda Pharmaceuticals Company Details

11.9.2 Vanda Pharmaceuticals Business Overview

11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction

11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025)

11.9.5 Vanda Pharmaceuticals Recent Development

11.10 ECR Pharmaceuticals

11.10.1 ECR Pharmaceuticals Company Details

11.10.2 ECR Pharmaceuticals Business Overview

11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction

11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025)

11.10.5 ECR Pharmaceuticals Recent Development

11.11 Fidia Farmaceutici

11.11.1 Fidia Farmaceutici Company Details

11.11.2 Fidia Farmaceutici Business Overview

11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction

11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2020-2025)

11.11.5 Fidia Farmaceutici Recent Development

11.12 Dainippon Sumitomo

11.12.1 Dainippon Sumitomo Company Details

11.12.2 Dainippon Sumitomo Business Overview

11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction

11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2020-2025)

11.12.5 Dainippon Sumitomo Recent Development

11.13 Biocodex

11.13.1 Biocodex Company Details

11.13.2 Biocodex Business Overview

11.13.3 Biocodex Insomnia Therapy Introduction

11.13.4 Biocodex Revenue in Insomnia Therapy Business (2020-2025)

11.13.5 Biocodex Recent Development

11.14 Eli Lilly and Company

11.14.1 Eli Lilly and Company Company Details

11.14.2 Eli Lilly and Company Business Overview

11.14.3 Eli Lilly and Company Insomnia Therapy Introduction

11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2020-2025)

11.14.5 Eli Lilly and Company Recent Development

11.15 Ebb Therapeutics

11.15.1 Ebb Therapeutics Company Details

11.15.2 Ebb Therapeutics Business Overview

11.15.3 Ebb Therapeutics Insomnia Therapy Introduction

11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2020-2025)

11.15.5 Ebb Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Eisai Co Ltd

Meda Consumer Healthcare

PERNIX Therapeutics

Vanda Pharmaceuticals

ECR Pharmaceuticals

Fidia Farmaceutici S.p.A

Dainippon Sumitomo

Biocodex

Eli Lilly and Company

Ebb Therapeutics

Pfizer Inc

Sanofi

Takeda Pharmaceutical Company Ltd

Purdue Pharmaceuticals L.P.

List of Tables

Table 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Non-pharmacological Therapy

Table 3. Key Players of Pharmacological Therapy

Table 4. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Insomnia Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Insomnia Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Insomnia Therapy Market Share by Region (2020-2025)

Table 8. Global Insomnia Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Insomnia Therapy Market Share by Region (2026-2031)

Table 10. Insomnia Therapy Market Trends

Table 11. Insomnia Therapy Market Drivers

Table 12. Insomnia Therapy Market Challenges

Table 13. Insomnia Therapy Market Restraints

Table 14. Global Insomnia Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Insomnia Therapy Market Share by Players (2020-2025)

Table 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2024)

Table 17. Ranking of Global Top Insomnia Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Insomnia Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Insomnia Therapy, Headquarters and Area Served

Table 20. Global Key Players of Insomnia Therapy, Product and Application

Table 21. Global Key Players of Insomnia Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Insomnia Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Insomnia Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global Insomnia Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Insomnia Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global Insomnia Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Insomnia Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global Insomnia Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Insomnia Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Insomnia Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Insomnia Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Insomnia Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Insomnia Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Insomnia Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Insomnia Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck & Co. Company Details

Table 47. Merck & Co. Business Overview

Table 48. Merck & Co. Insomnia Therapy Product

Table 49. Merck & Co. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 50. Merck & Co. Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Insomnia Therapy Product

Table 54. Sanofi Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 55. Sanofi Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Insomnia Therapy Product

Table 59. Pfizer Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Takeda Pharmaceutical Company Ltd. Company Details

Table 62. Takeda Pharmaceutical Company Ltd. Business Overview

Table 63. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product

Table 64. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 65. Takeda Pharmaceutical Company Ltd. Recent Development

Table 66. Purdue Pharmaceuticals L.P. Company Details

Table 67. Purdue Pharmaceuticals L.P. Business Overview

Table 68. Purdue Pharmaceuticals L.P. Insomnia Therapy Product

Table 69. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 70. Purdue Pharmaceuticals L.P. Recent Development

Table 71. Eisai, Co. Ltd. Company Details

Table 72. Eisai, Co. Ltd. Business Overview

Table 73. Eisai, Co. Ltd. Insomnia Therapy Product

Table 74. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 75. Eisai, Co. Ltd. Recent Development

Table 76. Meda Consumer Healthcare Company Details

Table 77. Meda Consumer Healthcare Business Overview

Table 78. Meda Consumer Healthcare Insomnia Therapy Product

Table 79. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 80. Meda Consumer Healthcare Recent Development

Table 81. Pernix Therapeutics Company Details

Table 82. Pernix Therapeutics Business Overview

Table 83. Pernix Therapeutics Insomnia Therapy Product

Table 84. Pernix Therapeutics Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 85. Pernix Therapeutics Recent Development

Table 86. Vanda Pharmaceuticals Company Details

Table 87. Vanda Pharmaceuticals Business Overview

Table 88. Vanda Pharmaceuticals Insomnia Therapy Product

Table 89. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 90. Vanda Pharmaceuticals Recent Development

Table 91. ECR Pharmaceuticals Company Details

Table 92. ECR Pharmaceuticals Business Overview

Table 93. ECR Pharmaceuticals Insomnia Therapy Product

Table 94. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 95. ECR Pharmaceuticals Recent Development

Table 96. Fidia Farmaceutici Company Details

Table 97. Fidia Farmaceutici Business Overview

Table 98. Fidia Farmaceutici Insomnia Therapy Product

Table 99. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 100. Fidia Farmaceutici Recent Development

Table 101. Dainippon Sumitomo Company Details

Table 102. Dainippon Sumitomo Business Overview

Table 103. Dainippon Sumitomo Insomnia Therapy Product

Table 104. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 105. Dainippon Sumitomo Recent Development

Table 106. Biocodex Company Details

Table 107. Biocodex Business Overview

Table 108. Biocodex Insomnia Therapy Product

Table 109. Biocodex Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 110. Biocodex Recent Development

Table 111. Eli Lilly and Company Company Details

Table 112. Eli Lilly and Company Business Overview

Table 113. Eli Lilly and Company Insomnia Therapy Product

Table 114. Eli Lilly and Company Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 115. Eli Lilly and Company Recent Development

Table 116. Ebb Therapeutics Company Details

Table 117. Ebb Therapeutics Business Overview

Table 118. Ebb Therapeutics Insomnia Therapy Product

Table 119. Ebb Therapeutics Revenue in Insomnia Therapy Business (2020-2025) & (US$ Million)

Table 120. Ebb Therapeutics Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Insomnia Therapy Picture

Figure 2. Global Insomnia Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Insomnia Therapy Market Share by Type: 2024 VS 2031

Figure 4. Non-pharmacological Therapy Features

Figure 5. Pharmacological Therapy Features

Figure 6. Global Insomnia Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Insomnia Therapy Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Insomnia Therapy Report Years Considered

Figure 12. Global Insomnia Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Insomnia Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Insomnia Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global Insomnia Therapy Market Share by Players in 2024

Figure 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2024

Figure 18. North America Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Insomnia Therapy Market Share by Country (2020-2031)

Figure 20. United States Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Insomnia Therapy Market Share by Country (2020-2031)

Figure 24. Germany Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Insomnia Therapy Market Share by Region (2020-2031)

Figure 32. China Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Insomnia Therapy Market Share by Country (2020-2031)

Figure 40. Mexico Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Insomnia Therapy Market Share by Country (2020-2031)

Figure 44. Turkey Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Insomnia Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 48. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 50. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 51. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 52. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 53. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 54. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 55. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 56. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 57. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 58. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 59. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 60. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 61. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions